SICKLE CELL DISEASE (HB 2021)

GLADWIN M.T.

ISBN 10: 1260458598 / ISBN 13: 9781260458596

Published by MCGRAWHILL (35), 2021

About this Item

Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Seller Inventory # Cvs 9781260458596

Bibliographic Details

• Title: SICKLE CELL DISEASE (HB 2021)
• Publisher: MCGRAWHILL (35)
• Publication Date: 2021
• Language: English
• ISBN 10: 1260458598
• ISBN 13: 9781260458596
• Binding: Hardcover
• Edition: International Edition
• Condition: New

About this title

Synopsis

The most comprehensive, current sickle cell disease resource―for both clinicians and researchers

A Doody's Core Title for 2024 & 2023!

The first and only resource of its kind, Sickle Cell Disease examines this blood disorder through both clinical and research lenses. More than 80 dedicated experts in the field present their combined clinical knowledge of basic mechanisms, screening, diagnosis, management, and treatment of myriad complex complications of a single base point mutation in the human genome. Case studies with “How I Treat” authoritative insights provide overviews of common and rare complications, and Key Facts offer at-a-glance high-yield information. 

Filled with clinical photos, illustrations, numerous original diagrams, and with free updates available online, this unmatched resource covers:

• Mechanisms of sickle cell disease
• Historic and current research approaches
• The latest work in gene therapy and editing
• Guidelines for patient care, diagnosis, unique cases, and therapies
• Rare and common complications, including domestic and internationally relevant topics
• Psychosocial and supportive care
• The newest standards of therapy and future treatment options in children and adults
• Cardiopulmonary complications

A Doody's Core Title for 2022!

 

About the Author

Mark T. Gladwin, MD, is Professor and Chairman, Department of Medicine, University of Pittsburgh, and Director, Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute.

Gregory J. Kato, MD, is Professor of Medicine, Division of Hematology/Oncology, University of Pittsburgh, and Director, University of Pittsburgh’s Sickle Cell Center of Excellence.

Enrico M. Novelli, MD, is Associate Professor of Medicine, Division of Hematology/Oncology, University of Pittsburgh, and Director, University of Pittsburgh Medical Center’s Adult Sickle Cell Disease Program.